Search Results - "Allam, Sherihan H."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    TLR4 gene polymorphisms in Egyptian vitiligo patients: insights into emerging association with clinical activity, family history, and response to therapy by Abdelsalam, Maha, Allam, Sherihan H., Zohdy, Marwa, Magdy, Hend, Mostafa, Maged

    “…BackgroundVitiligo is a common pigmentary disorder in which autoimmunity has been suggested to play an important role. Toll-like receptor (TLR) family are…”
    Get full text
    Journal Article
  2. 2

    Expression of p16 protein in lesional and perilesional condyloma acuminata and bowenoid papulosis: Clinical significance and diagnostic implications by Kazlouskaya, Viktoryia, MD, PhD, Shustef, Elina, DO, Allam, Sherihan H., MD, Lal, Karan, BS, Elston, Dirk, MD

    “…Background The histopathological and clinical overlapping features between condyloma acuminata and bowenoid papulosis can present a diagnostic challenge and we…”
    Get full text
    Journal Article
  3. 3

    Simvastatin and non‐segmental vitiligo: A new potential treatment option? by Shaker, Engi Seif E., Allam, Sherihan H., Mabrouk, Maaly M., Elgharbawy, Nashwa M., Salaam, Shady Fikry Abdel

    Published in Dermatologic therapy (01-12-2022)
    “…There is a paucity of data about the impact of systemic statins on vitiliginous lesions in non‐segmental vitiligo (NSV) patients. To the best of our knowledge,…”
    Get full text
    Journal Article
  4. 4

    Mixed Versus Pure Variants of Desmoplastic Melanoma: The Cleveland Clinic Experience by Conic, Ruzica Z, Ko, Jennifer, Allam, Sherihan H, Atanaskova-Mesinkovska, Natasha, Kovalyshyn, Ivanka, Bergfeld, Wilma, Gastman, Brian R

    Published in Annals of plastic surgery (01-03-2018)
    “…BACKGROUNDDesmoplastic melanoma (DM) is a subvariant of spindle cell melanoma, accounting for less than 4% of all cutaneous melanomas. It occurs later in life…”
    Get full text
    Journal Article
  5. 5